Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-17-060942
Filing Date
2017-11-27
Accepted
2017-11-27 16:06:02
Documents
4
Group Members
DILIP S. SHANGHVISUN PHARMA (NETHERLANDS) B.V.SUN PHARMACEUTICAL INDUSTRIES INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tv480243_sc13d.htm SC 13D 122987
2 EXHIBIT 10.2 tv480243_ex10-2.htm EX-10.2 40998
3 EXHIBIT 99.1 tv480243_ex99-1.htm EX-99.1 7940
4 EXHIBIT 99.2 tv480243_ex99-2.htm EX-99.2 10557
  Complete submission text file 0001144204-17-060942.txt   184243
Mailing Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093
Business Address 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD ANDEHERI (EAST) K7 400 093 01191228212128
SUN PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0001197089 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0331
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90193 | Film No.: 171222962
SIC: 2834 Pharmaceutical Preparations